Endovascular Treatment in Ischemic Stroke Follow-up Evaluation

NCT ID: NCT03776877

Last Updated: 2022-08-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

4000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-06-26

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study like register with biomarkers samples for patient experiencing acute ischemic stroke, to assess clinical outcomes and different factors that may affect the clinical outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke, Acute

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arterial Ischemic Stroke (AIS)

All patients (prospective and retrospective) included will have to present an Arterial Ischemic Stroke (AIS) from a large cerebral vessel occlusion.

The participation in the study will consist in:

* Plasmatic collection at the time of AIS, for study of plasma biomarkers
* Additional standardized blinded clinical evaluation at three months after the thrombectomy realized during a phone call, particularly via an assessment of the modified Rankin score.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 and older (i.e., candidates must have had their 18th birthday)
* Neuroimaging demonstrates acute ischemic stroke with large vessel proximal with the use of neuro-thrombectomy devices intended to restore blood flow
* No upper or lower limits of the neurological severity at baseline (NIHSS).
* With or without intravenous thrombolysis
* Oral informed consent (patient and/or trustworthy person)


* Pregnant or breast-feeding women
* Patient benefiting from a legal protection
* Non-membership of a national insurance scheme
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hopital Foch

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bertrand Larpergue, MD

Role: PRINCIPAL_INVESTIGATOR

Hopital Foch

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Bordeaux

Bordeaux, , France

Site Status RECRUITING

CHU de Caen

Caen, , France

Site Status RECRUITING

Hôpital le Kremlin-Bicètre - APHP

Le Kremlin-Bicêtre, , France

Site Status RECRUITING

CHU Dupuytren

Limoges, , France

Site Status RECRUITING

CHU Lyon

Lyon, , France

Site Status NOT_YET_RECRUITING

CHU Montpellier

Montpellier, , France

Site Status RECRUITING

CHU Nancy

Nancy, , France

Site Status RECRUITING

CHU Nantes

Nantes, , France

Site Status RECRUITING

Hôpital Pitié Salpétrière

Paris, , France

Site Status RECRUITING

Hôpital SAINTE ANNE

Paris, , France

Site Status RECRUITING

Fondation Ophtalmique de Rotschild

Paris, , France

Site Status RECRUITING

CHU Rennes

Rennes, , France

Site Status RECRUITING

Chu Rouen

Rouen, , France

Site Status RECRUITING

Hôpital Foch

Suresnes, , France

Site Status RECRUITING

CHU Toulouse

Toulouse, , France

Site Status RECRUITING

CH Bretagne Atlantique

Vannes, , France

Site Status ACTIVE_NOT_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Elisabeth Hulier-Ammar

Role: CONTACT

+33146251175

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gaultier Marnat, MD

Role: primary

Emmanuel TOUZE, PhD

Role: primary

Laurent Spelle, MD

Role: primary

Charbel MOUNAYER, MD

Role: primary

Omer Eker, MD

Role: primary

Cyril Dargazanli, MD

Role: primary

Benjamin Gory, MD

Role: primary

Romain Bourcier, MD

Role: primary

Frédéric CLARENCON, MD

Role: primary

Olivier NAGARRA, MD

Role: primary

Raphael Blanc, MD

Role: primary

Jean-Christophe Ferre, MD

Role: primary

Olzem OZKUL-WERMESTER, MD

Role: primary

Bertrand Lapergue, MD

Role: primary

+33(0)1 46 25 73 43

Alain VIGUIER, MD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Milnerowicz M, Desilles JP, Pop R, Dargazanli C, Labreuche J, Sibon I, Gory B, Soize S, Bourcier R, Mazighi M, Cognard C, Caroff J, Gentric JC, Clarencon F, Richter S, Janot K, Lapergue B, Marnat G; ETIS investigators. Cangrelor versus GPIIb/IIIa inhibitors as adjunctive therapy in endovascular treatment of large vessel occlusion stroke. J Neurointerv Surg. 2025 May 2:jnis-2025-023260. doi: 10.1136/jnis-2025-023260. Online ahead of print.

Reference Type DERIVED
PMID: 40316319 (View on PubMed)

Dargazanli C, Mourand I, Mahmoudi M, Poirier L, Labreuche J, Weisenburger-Lile D, Gory B, Richard S, Ducroux C, Piotin M, Blanc R, Lucas L, Marnat G, Aubertin M, Arquizan C, Bourcier R, Detraz L, Vannier S, Guillen M, Eugene F, Walker G, Lun R, Dowlatshahi D, Shamy M, Consoli A, Costalat V, Lapergue B, Maier B, Guenego A, Fahed R. Endovascular treatment versus medical management for basilar artery occlusion with low-to-moderate symptoms (National Institutes of Health Stroke Scale < 10). Eur Stroke J. 2025 Jun;10(2):397-405. doi: 10.1177/23969873241290442. Epub 2024 Oct 13.

Reference Type DERIVED
PMID: 39397363 (View on PubMed)

Derraz I, Moulin S, Gory B, Kyheng M, Arquizan C, Costalat V, Lapergue B; ETIS Investigators. Endovascular Thrombectomy Outcomes with and without Intravenous Thrombolysis for Large Ischemic Cores Identified with CT or MRI. Radiology. 2023 Oct;309(1):e230440. doi: 10.1148/radiol.230440.

Reference Type DERIVED
PMID: 37847131 (View on PubMed)

Malka D, Janot K, Pasi M, Desilles JP, Marnat G, Sibon I, Consoli A, Dargazanli C, Arquizan C, Gory B, Richard S, Naggara O, Clarencon F, Rosso C, Bourcier R, Eker O, Caroff J, Lapergue B, Boulouis G; ETIS collaborators. Effects of weather conditions on endovascular treatment case volume for patients with ischemic stroke. J Neuroradiol. 2023 Nov;50(6):593-599. doi: 10.1016/j.neurad.2023.07.001. Epub 2023 Jul 11.

Reference Type DERIVED
PMID: 37442271 (View on PubMed)

Bourcier R, Consoli A, Desilles JP, Labreuche J, Kyheng M, Desal H, Alias Q, Gory B, Dargazanli C, Janot K, Zhu F, Lapergue B, Marnat G. Temporal trends in results of endovascular treatment of anterior intracranial large cerebral vessel occlusion: A 7-year study. Eur Stroke J. 2023 Sep;8(3):655-666. doi: 10.1177/23969873231180338. Epub 2023 Jun 8.

Reference Type DERIVED
PMID: 37288701 (View on PubMed)

Douarinou M, Gory B, Consoli A, Lapergue B, Kyheng M, Labreuche J, Anadani M, Blanc R, Marnat G, Bourcier R, Sibon I, Eugene F, Vannier S, Audibert G, Mione G, Richard S; ETIS Investigators. Impact of Strategy on Clinical Outcome in Large Vessel Occlusion Stroke Successfully Reperfused: ETIS Registry Results. Stroke. 2022 Jan;53(1):e1-e4. doi: 10.1161/STROKEAHA.121.034422. Epub 2021 Nov 3.

Reference Type DERIVED
PMID: 34727741 (View on PubMed)

Happi Ngankou E, Gory B, Marnat G, Richard S, Bourcier R, Sibon I, Dargazanli C, Arquizan C, Maier B, Blanc R, Lapergue B, Consoli A, Vannier S, Spelle L, Denier C, Boulanger M, Gauberti M, Saleme S, Macian F, Clarencon F, Rosso C, Naggara O, Turc G, Ozkul-Wermester O, Papagiannaki C, Viguier A, Cognard C, Lebras A, Evain S, Wolff V, Pop R, Timsit S, Gentric JC, Bourdain F, Veunac L, Eugene F, Finitsis S; ETIS Registry Investigatorsdagger. Thrombectomy Complications in Large Vessel Occlusions: Incidence, Predictors, and Clinical Impact in the ETIS Registry. Stroke. 2021 Dec;52(12):e764-e768. doi: 10.1161/STROKEAHA.121.034865. Epub 2021 Oct 28.

Reference Type DERIVED
PMID: 34706564 (View on PubMed)

Aubertin M, Weisenburger-Lile D, Gory B, Richard S, Blanc R, Ducroux C, Piotin M, Labreuche J, Lucas L, Dargazanli C, Benali A, Bourcier R, Detraz L, Vannier S, Guillen M, Eugene F, Walker G, Lun R, Guenego A, Consoli A, Marnat G, Maier B, Lapergue B, Fahed R; ETIS Investigators*. First-Pass Effect in Basilar Artery Occlusions: Insights From the Endovascular Treatment of Ischemic Stroke Registry. Stroke. 2021 Dec;52(12):3777-3785. doi: 10.1161/STROKEAHA.120.030237. Epub 2021 Aug 26.

Reference Type DERIVED
PMID: 34433309 (View on PubMed)

Ducroux C, Renaud N, Bourcier R, Marnat G, Sibon I, Gory B, Richard S, Dargazanli C, Arquizan C, Eugene F, Vannier S, Labreuche J, Walker G, Blanc R, Obadia M, Consoli A, Lapergue B, Fahed R; ETIS investigators. Embolus Retriever with Interlinked Cages (ERIC) versus conventional stent retrievers for thrombectomy: a propensity score-based analysis. J Neurointerv Surg. 2021 Mar;13(3):255-260. doi: 10.1136/neurintsurg-2020-016289. Epub 2020 Jun 30.

Reference Type DERIVED
PMID: 32606101 (View on PubMed)

Boisseau W, Fahed R, Lapergue B, Desilles JP, Zuber K, Khoury N, Garcia J, Maier B, Redjem H, Ciccio G, Smajda S, Escalard S, Taylor G, Mazighi M, Michel P, Gory B, Blanc R; ETIS Investigators. Predictors of Parenchymal Hematoma After Mechanical Thrombectomy: A Multicenter Study. Stroke. 2019 Sep;50(9):2364-2370. doi: 10.1161/STROKEAHA.118.024512. Epub 2019 Jul 22.

Reference Type DERIVED
PMID: 31670928 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017024F

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.